ATE408831T1 - Nachweisverfahren für delta-9- tetrahydrocannabinol - Google Patents

Nachweisverfahren für delta-9- tetrahydrocannabinol

Info

Publication number
ATE408831T1
ATE408831T1 AT05754731T AT05754731T ATE408831T1 AT E408831 T1 ATE408831 T1 AT E408831T1 AT 05754731 T AT05754731 T AT 05754731T AT 05754731 T AT05754731 T AT 05754731T AT E408831 T1 ATE408831 T1 AT E408831T1
Authority
AT
Austria
Prior art keywords
cannabis
testing
delta
employing
conjugate
Prior art date
Application number
AT05754731T
Other languages
English (en)
Inventor
Ahmed Jehanli
Christopher Hand
Original Assignee
Cozart Bioscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cozart Bioscience Ltd filed Critical Cozart Bioscience Ltd
Application granted granted Critical
Publication of ATE408831T1 publication Critical patent/ATE408831T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525Multi-layer analytical elements
    • G01N33/526Multi-layer analytical elements the element being adapted for a specific analyte
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948Sedatives, e.g. cannabinoids, barbiturates
AT05754731T 2004-07-02 2005-07-01 Nachweisverfahren für delta-9- tetrahydrocannabinol ATE408831T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0414898A GB2404023B (en) 2004-07-02 2004-07-02 Delta-9-tetrahydrocannabinol detection method

Publications (1)

Publication Number Publication Date
ATE408831T1 true ATE408831T1 (de) 2008-10-15

Family

ID=32843498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05754731T ATE408831T1 (de) 2004-07-02 2005-07-01 Nachweisverfahren für delta-9- tetrahydrocannabinol

Country Status (10)

Country Link
US (1) US7790400B2 (de)
EP (1) EP1825262B1 (de)
CN (1) CN1981193B (de)
AT (1) ATE408831T1 (de)
AU (1) AU2005258886B2 (de)
DE (1) DE602005009863D1 (de)
ES (1) ES2311994T3 (de)
GB (1) GB2404023B (de)
HK (1) HK1102308A1 (de)
WO (1) WO2006003472A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2404022B (en) 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
GB2404023B (en) * 2004-07-02 2005-07-06 Cozart Bioscience Ltd Delta-9-tetrahydrocannabinol detection method
CN101495865B (zh) * 2005-05-20 2015-01-28 北京玛诺生物制药有限公司 口腔流体快速免疫层析检测
WO2007132373A1 (en) * 2006-05-09 2007-11-22 Koninklijke Philips Electronics N. V. Detection of target molecules in a sample by using a magnetic field
CN101078715B (zh) * 2007-06-28 2010-12-08 艾博生物医药(杭州)有限公司 一种标准品溶液及其配制方法和应用
GB0725234D0 (en) * 2007-12-24 2008-02-06 Oxtex Ltd Electrochemical assays
KR101029306B1 (ko) 2010-07-23 2011-04-14 대한민국 대마 대사체 분석방법
SG194892A1 (en) * 2011-05-12 2013-12-30 Univ Rice William M Bio-nano-chips for on-site drug screening
ES2523682B1 (es) * 2011-06-27 2016-05-09 V.P. Pharma Baru, S.L. Sistema para la detección de drogas de abuso
US10408786B2 (en) 2012-06-14 2019-09-10 ChemiSensor, LLP Distributable chemical sampling and sensing system
WO2014051998A1 (en) 2012-09-28 2014-04-03 Clontech Laboratories, Inc. Lateral flow assays for tagged analytes
US20150369830A1 (en) * 2013-01-30 2015-12-24 Thcer Llc Articles and methods for rapid thc detection
US9970950B1 (en) 2014-03-09 2018-05-15 Hound Labs, Inc. Method and apparatus for detecting acute use of target substance(s)
KR102387044B1 (ko) 2014-03-18 2022-04-14 이준 파마슈티컬스 코퍼레이션 단백질-결합된 칸나비노이드 조성물
CA2850998A1 (en) * 2014-04-18 2015-10-18 Thc Breathalyzer, Inc. Cannabis drug detection device
GB2528657B (en) * 2014-07-24 2019-03-13 Intelligent Fingerprinting Ltd Sample analysing device
US10331275B2 (en) 2014-07-31 2019-06-25 Hewlett-Packard Development Company, L.P. Process image according to mat characteristic
US9726684B1 (en) 2015-01-18 2017-08-08 Hound Labs, Inc. Compositions for target substance detection and measurement
US10254298B1 (en) 2015-03-25 2019-04-09 National Technology & Engineering Solutions Of Sandia, Llc Detection of metabolites for controlled substances
CN107709572A (zh) * 2015-05-20 2018-02-16 谷万达公司 促进从动物饲料中提取酶的方法及酶活性的测定方法
US9817006B2 (en) * 2015-06-19 2017-11-14 Amy J. Reisinger Rapid and sensitive method of forensic toxicology in post-mortem subjects using oral fluid testing
US20170023453A1 (en) * 2015-07-24 2017-01-26 Washington State University Particle-based drug detection methods
US11726102B2 (en) 2015-07-24 2023-08-15 Washington State University Particle-based drug detection method and device embodiments
US9933445B1 (en) 2016-05-16 2018-04-03 Hound Labs, Inc. System and method for target substance identification
US10458963B2 (en) 2016-06-08 2019-10-29 Kathleen Stitzlein Quantitative HPTLC cannabinoid field testing device and method
US9921234B1 (en) 2016-06-17 2018-03-20 Hound Labs, Inc. Compositions and methods for detection of target constituent in exhaled breath
US10981174B1 (en) 2016-08-04 2021-04-20 National Technology & Engineering Solutions Of Sandia, Llc Protein and nucleic acid detection for microfluidic devices
US11712200B2 (en) 2017-04-28 2023-08-01 University of Pittsburgh—of the Commonwealth System of Higher Education Nanostructure-based cannabinoid sensor
US11026596B1 (en) 2017-05-19 2021-06-08 Hound Labs, Inc. Detection and measurement of target substance in exhaled breath
WO2019018697A1 (en) 2017-07-19 2019-01-24 Evanostics, Llc CARTRIDGES FOR ORAL FLUID ANALYSIS AND METHODS OF USE
US11187711B1 (en) 2017-09-11 2021-11-30 Hound Labs, Inc. Analyte detection from breath samples
WO2019118989A1 (en) 2017-12-15 2019-06-20 Evanostics Llc Optical reader for analyte testing
US11426097B1 (en) * 2018-10-17 2022-08-30 Hound Labs, Inc. Rotary valve assemblies and methods of use for breath sample cartridge systems
US20200245899A1 (en) 2019-01-31 2020-08-06 Hound Labs, Inc. Mechanical Breath Collection Device
WO2020167828A1 (en) 2019-02-11 2020-08-20 Giner, Inc. Method and system for detection and/or quantification of delta-9-tetrahydrocannabinol in exhaled breath
US11977086B2 (en) 2019-03-21 2024-05-07 Hound Labs, Inc. Biomarker detection from breath samples
US20210003488A1 (en) * 2019-07-03 2021-01-07 Pinpoint Testing, Llc Ready-to-extract platforms for chemical analysis and quantification of unknown samples using spiked matrix standards
US11493451B2 (en) * 2019-12-23 2022-11-08 Palo Alto Research Center Incorporated Colorimetric drug test strip using porous support material
US11933731B1 (en) 2020-05-13 2024-03-19 Hound Labs, Inc. Systems and methods using Surface-Enhanced Raman Spectroscopy for detecting tetrahydrocannabinol
US11806711B1 (en) 2021-01-12 2023-11-07 Hound Labs, Inc. Systems, devices, and methods for fluidic processing of biological or chemical samples using flexible fluidic circuits

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067774A (en) 1971-05-14 1978-01-10 Syva Company Compounds for enzyme amplification assay
US5840588A (en) * 1971-05-20 1998-11-24 Strahilevitz; Meir Agglutination inhibition assay methods and reagents for psychoactive substances
US3996344A (en) 1972-05-15 1976-12-07 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies and use
US4041076A (en) 1974-10-23 1977-08-09 Hoffmann-La Roche Inc. Immunoassay for pharmacologically active phenethylamines
US4016146A (en) 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
US4329281A (en) 1978-06-05 1982-05-11 Hoffmann-La Roche Inc. Hapten compositions
US4771005A (en) * 1983-06-27 1988-09-13 Erez Forensic Technology Ltd. Reagents, test kits and methods for the detection of cannabinoids
US5223441A (en) * 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
US4868132A (en) 1987-02-03 1989-09-19 Abbott Laboratories Fluorescence polarization immunoassay for amphetamine/methamphetamine
US5144030A (en) * 1987-02-17 1992-09-01 Abbott Laboratories Fluorescene polarization immunoassay for tetrahydrocannabinoids
ATE225509T1 (de) 1987-04-27 2002-10-15 Inverness Medical Switzerland Testgerät zur durchführung von spezifischen bindungsprüfungen
US4843020A (en) * 1988-01-14 1989-06-27 Woodford W James Method for detecting tetrahydrocannabinol in human urine involving melanin precipitation
US5026827A (en) 1988-09-02 1991-06-25 Matsushita Electric Industrial Co., Ltd. Amphetamine-protein complex as immunogen for obtaining antibodies specific to methamphetamine
EP0371253B1 (de) 1988-10-28 1995-09-13 Abbott Laboratories Verfahren und Reagenzien zum Nachweis von Amphetamin und/oder d-Methamphetamin in biologischen Proben
US5248791A (en) 1989-04-10 1993-09-28 Abbott Laboratories Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
US5279955A (en) * 1991-03-01 1994-01-18 Pegg Randall K Heterofunctional crosslinking agent for immobilizing reagents on plastic substrates
US5237057A (en) * 1992-04-06 1993-08-17 Biosite Diagnostics, Inc. Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
KR0155608B1 (ko) 1995-07-14 1998-12-01 박홍기 원적외선 방사성 폴리에스테르 섬유의 제조방법
GB2339615B (en) 1998-07-14 2001-02-07 Cozart Bioscience Ltd Screening device and method of screening an immunoassay test
CA2362698C (en) * 1999-03-22 2005-02-01 Pfizer Inc. Resorcinol derivatives
GB2361473C (en) 2000-03-08 2005-06-28 Microgenics Corp Ecstasy-class analogs and use of same in detection of ecstasy-class compounds
US6534325B1 (en) 2000-06-30 2003-03-18 Roche Diagnostics Corporation Immunoassay for the detection of amphetamines, methamphetamines and methylenedioxy designer amphetamines
SE0002820L (sv) * 2000-08-04 2002-02-05 Jordanian Pharmaceutical Mfg & Medicinskt kit
US6472228B2 (en) 2000-12-04 2002-10-29 Lifepoint, Inc. Composition and methods for synthesis of novel tracers for detecting amphetamine and methamphetamine in samples
US7169907B2 (en) 2002-03-01 2007-01-30 Roche Diagnostics Operations, Inc. Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs
GB0405999D0 (en) 2004-03-17 2004-04-21 Cozart Bioscience Ltd Procedure for manufacture of strips for lateral flow immunochromatographic devices
GB2404022B (en) 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
GB2404023B (en) 2004-07-02 2005-07-06 Cozart Bioscience Ltd Delta-9-tetrahydrocannabinol detection method

Also Published As

Publication number Publication date
EP1825262A1 (de) 2007-08-29
GB2404023B (en) 2005-07-06
GB2404023A8 (en) 2005-01-20
WO2006003472A1 (en) 2006-01-12
AU2005258886A1 (en) 2006-01-12
HK1102308A1 (en) 2007-11-16
US7790400B2 (en) 2010-09-07
CN1981193A (zh) 2007-06-13
GB2404023A (en) 2005-01-19
AU2005258886B2 (en) 2007-10-11
GB0414898D0 (en) 2004-08-04
US20090017555A1 (en) 2009-01-15
EP1825262B1 (de) 2008-09-17
CN1981193B (zh) 2012-02-01
DE602005009863D1 (de) 2008-10-30
ES2311994T3 (es) 2009-02-16

Similar Documents

Publication Publication Date Title
ATE408831T1 (de) Nachweisverfahren für delta-9- tetrahydrocannabinol
DK1322956T3 (da) Fremgangsmåde til diagnose af immunologisk födevarefölsomhed
WO2005093414A3 (en) Assay devices utilizing chemichromic dyes
WO2006089027A3 (en) Lateral flow test kit and method for detecting an analyte
GB2449043A (en) Water soluble conjugates for electrochemical detection
ATE497163T1 (de) Flüssigprobenanalysevorrichtung mit verschliessbarem probenaufbewahrungsreservoir
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
WO2009094058A3 (en) Real-time, single-step bioassay using nanoplasmonic resonator with ultra-high sensitivity
ATE478338T1 (de) Internes kalibriersystem für durchflusstests
CA2863353C (en) Devices, methods, and test kits for electronic analyte assaying
AU2004256206A1 (en) Device and method for simultaneous carrying out of blood group determination, serum cross-check and antibody detection test
BRPI0915086B8 (pt) detecção do uso de canabis
WO2008030546A3 (en) Lateral flow test strip with migrating label
RU2008136193A (ru) Детектирование рака по повышенным уровням bcl-2
BRPI0509068A (pt) métodos para determinar quantitativamente heparinas de constituição especìfica ou heparinas de baixo peso molecular usando hplc
RU2013118695A (ru) Устройства, способы и наборы для иммунохроматографии
BRPI0408255A (pt) sistema de processamento de sinal e método
GB2431240A (en) Improvements in or relating to lateral flow assay devices
EP1494030A3 (de) Lösung zur Vorbehandlung eines Grippevirentests basierend auf Immunchromatographie
Nieddu et al. Evaluation of commercial multi-drug oral fluid devices to identify 39 new amphetamine-designer drugs
BRPI0519011A2 (pt) marcador para leituras feitas em testes em locais alternativos
AR050213A1 (es) Ensayo de diagnostico ileitis
NO20071971L (no) System og fremgangsmate for a reposisjonere en diagnostisk teststrip etter inokulasjon
AU2003215467A1 (en) Method and device for predicting cardiovascular events
ATE369564T1 (de) Differenzielles immunoassay für myoglobin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee